Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
181 - 190 out of 273Page size: 10
Sort by: 1st author
  1. Published

    Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

    Lorentzen, C. L., Kjeldsen, J. W., Ehrnrooth, E., Andersen, M. H. & Svane, Inge Marie, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5, 10 p., e006755.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Clinical advances and ongoing trials on mRNA vaccines for cancer treatment

    Lorentzen, C. L., Haanen, J. B., Met, Özcan & Svane, Inge Marie, 2022, In: The Lancet Oncology. 23, 10, p. e450-e458

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Frequent adaptive immune responses against arginase-1

    Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Peripheral memory T cells specific for Arginase-1

    Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  5. Published

    CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

    Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

    Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cancer Immunology, Immunotherapy. 68, 11, p. 1901-1907 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: Effects on their immunogenic potential

    Met, O., Eriksen, J. & Svane, Inge Marie, 2008, In: Journal of Molecular Microbiology and Biotechnology. 40, 2, p. 151-160 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential

    Met, Özcan, Eriksen, J. & Svane, Inge Marie, Oct 2008, In: Molecular Biotechnology. 40, 2, p. 151-60 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

    Met, Özcan, Balslev, E., Flyger, H. & Svane, Inge Marie, 1 Jan 2011, In: Breast Cancer Research and Treatment. 125, 2, p. 395-406 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Analysis of Survivin-Specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin mRNA

    Met, Özcan & Svane, Inge Marie, 2013, Synthetic Messenger RNA and Cell Metabolism Modulation. Vol. 969. p. 275-292 18 p. (Methods in Molecular Biology).

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Previous 1...15 16 17 18 19 20 21 22 ...28 Next

ID: 4054758